Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Multiple Myeloma-Specific Targeted Therapy: Use of the Tumor Specific Immunoglobulin Gene Sequence to Activate Drugs Only within Tumor Cells.

Zhi-Wei Li, PhD, Dror Shalitin, PhD, Jennifer Finefield, Crystal Leung, Mengyin Hu, Jing Shen, Mingjie Li, Cathy S Wang, Jeffrey A Steinberg, Eric Sanchez, Haiming Chen, MD, PhD, Robert M Williams, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 1851.

https://doi.org/10.1182/blood.V114.22.1851.1851

Published: 2009

Journal Articles

A Novel Targeted Therapeutic Approach to Multiple Myeloma Using Tumor Specific Anti-Sense RNA Sequences

Zhi-Wei Li, PhD, Dror Shalitin, PhD, Jing Shen, Michael Share, Mingjie Li, Cathy S Wang, Eric Sanchez, Jeffrey A Steinberg, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 2727.

https://doi.org/10.1182/blood.V112.11.2727.2727

Published: 2008

Journal Articles

Blockage of TRAF6 Signaling Inhibits Osteoclast Formation and Tumor Cell through Blocking the NF-kB and JNK Pathways in Multiple Myeloma.

Haiming Chen, MD, PhD, Mingjie Li, Jennifer Li, Richard A. Campbell, Cathy S. Wang, Eric Sanchez, Jeffrey Steinberg, Michael Share, Dror Shalitin, PhD, James Wang, Shi-Jason Xie, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2007) 110 (11): 2511.

https://doi.org/10.1182/blood.V110.11.2511.2511

Published: 2007

Journal Articles

Wnt/β-Catenin Signaling Is Essential for the Transdifferentiation of Monocytes into Endothelial Cells by mCSF and Pleiotrophin.

Haiming Chen, MD, PhD, Mingjie Li, Richard Campbell, Cathy S. Wang, Jennifer Li, Eric Sanchez, Jeffrey Steinberg, Michael Share, Dror Shalitin, PhD, James Wang, Shi-Jason Xie, Yunchao Chang, PhD, Benjamin Bonavida, PhD, Thomas F. Deuel, MD, James R. Berenson, MD

Blood (2007) 110 (11): 1512.

https://doi.org/10.1182/blood.V110.11.1512.1512

Published: 2007

Journal Articles

Zoledronic Acid Suppresses Vasculogenesis: A New Effect of Bisphosphonates.

Haiming Chen, MD, PhD, Cathy S. Wang, Jennifer Li, Richard A. Campbell, Mingjie Li, Eric Sanchez, Jeffrey Steinberg, Michael Share, Dror Shalitin, PhD, James Wang, Shi-Jason Xie, Yunchao Chang, MD, Benjamin Bonavida, PhD, Thomas F. Deuel, MD, James R. Berenson, MD

Blood (2007) 110 (11): 3913.

https://doi.org/10.1182/blood.V110.11.3913.3913

Published: 2007

Journal Articles

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 2520.

https://doi.org/10.1182/blood.V110.11.2520.2520

Published: 2007

Journal Articles

The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.

Dror Shalitin, PhD, Michael Share, BA, Richard A. Campbell, BS, Jeffrey Steinberg, BS, Eric Sanchez, BA, Joseph Wang, Richard Leuchter, Mingjie Li, Cathy S. Wang, BS, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2007) 110 (11): 4800.

https://doi.org/10.1182/blood.V110.11.4800.4800

Published: 2007

Journal Articles

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Richard Leuchter, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 4801.

https://doi.org/10.1182/blood.V110.11.4801.4801

Published: 2007

Journal Articles

An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Blood (2007) 110 (11): 4802.

https://doi.org/10.1182/blood.V110.11.4802.4802

Published: 2007

Journal Articles

Arsenic Trioxide Affects Early Stage Angiogenesis through Inhibition of CD14 Monocyte Transdifferentiation into Endothelial Cells Induced by Pleiotrophin and mCSF.

Haiming Chen, MD, PhD, Mingjie Li, Richard A. Campbell, Melinda S. Gordon, PhD, Dror Shalitin, PhD, Cathy S. Wang, Ariana M. Berenson, Jennifer Li, Hetty Wong, James Wang, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2006) 108 (11): 1267.

https://doi.org/10.1182/blood.V108.11.1267.1267

Published: 2006

Journal Articles

Pleiotrophin Is Highly Produced by Myeloma and Breast Cancer and Transdifferentiates Human Monocytes into Endothelial Cells That Are Incorporated into Tumoral Blood Vessels.

Haiming Chen, MD, PhD, Richard A. Campbell, Mingjie Li, Melinda S. Gordon, PhD, Dror Shalitin, PhD, Cathy S. Wang, Ariana M. Berenson, Jennifer Li, Hetty Wong, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2006) 108 (11): 1269.

https://doi.org/10.1182/blood.V108.11.1269.1269

Published: 2006

Journal Articles

PK11195, a Ligand of the Peripheral Benzodiazepine Receptor, Inhibits Myeloma Cell Growth In Vitro and Chemosensitizes Myeloma Cells In Vivo in SCID-hu Models of Human Multiple Myeloma.

Richard A. Campbell, Eric Sanchez, Haiming Chen, MD, PhD, Lauren Turker, Olivia Trac, Mingjie Li, Dror Shalitin, PhD, Melinda S. Gordon, PhD, Shen Pang, PhD, Benjamin Bonavida, PhD, Jonathan Said, MD, Ronald J. Berenson, MD, James R. Berenson, MD

Blood (2006) 108 (11): 3459.

https://doi.org/10.1182/blood.V108.11.3459.3459

Published: 2006

Journal Articles

Effects of a Novel Histone Deacetylase Inhibitor, PXD101, When Used as Monotherapy or in Combination with Bortezomib on Tumor Growth in Mouse Models of Human Multiple Myeloma.

Blood (2006) 108 (11): 3483.

https://doi.org/10.1182/blood.V108.11.3483.3483

Published: 2006

Journal Articles

Anti-VEGF Antibody Treatment Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Blood (2006) 108 (11): 846.

https://doi.org/10.1182/blood.V108.11.846.846

Published: 2006

NARROW

Multiple Myeloma-Specific Targeted Therapy: Use of the Tumor Specific Immunoglobulin Gene Sequence to Activate Drugs Only within Tumor Cells.

A Novel Targeted Therapeutic Approach to Multiple Myeloma Using Tumor Specific Anti-Sense RNA Sequences

Blockage of TRAF6 Signaling Inhibits Osteoclast Formation and Tumor Cell through Blocking the NF-kB and JNK Pathways in Multiple Myeloma.

Wnt/β-Catenin Signaling Is Essential for the Transdifferentiation of Monocytes into Endothelial Cells by mCSF and Pleiotrophin.

Zoledronic Acid Suppresses Vasculogenesis: A New Effect of Bisphosphonates.

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Arsenic Trioxide Affects Early Stage Angiogenesis through Inhibition of CD14 Monocyte Transdifferentiation into Endothelial Cells Induced by Pleiotrophin and mCSF.

Pleiotrophin Is Highly Produced by Myeloma and Breast Cancer and Transdifferentiates Human Monocytes into Endothelial Cells That Are Incorporated into Tumoral Blood Vessels.

PK11195, a Ligand of the Peripheral Benzodiazepine Receptor, Inhibits Myeloma Cell Growth In Vitro and Chemosensitizes Myeloma Cells In Vivo in SCID-hu Models of Human Multiple Myeloma.

Effects of a Novel Histone Deacetylase Inhibitor, PXD101, When Used as Monotherapy or in Combination with Bortezomib on Tumor Growth in Mouse Models of Human Multiple Myeloma.

Anti-VEGF Antibody Treatment Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only